Atlas Trials

Evaluating Tocilizumab for Sever COVID-19 Infection in Breast Cancer vs. Non Cancer Pateints

Clinical trial NCT04871854 · COMPLETED

Trial details

NCT number
NCT04871854
Sponsor
Beni-Suef University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2021-04-26
Primary completion
2022-07-26
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.